1-((BENZYLOXY)CARBONYL)-3-AMINOPIPERIDINE-3-CARBOXYLIC ACID

97%

Reagent Code: #141689
fingerprint
CAS Number 1131595-03-3

science Other reagents with same CAS 1131595-03-3

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 278.3037 g/mol
Formula C₁₄H₁₈N₂O₄
badge Registry Numbers
MDL Number MFCD11110741
thermostat Physical Properties
Boiling Point 469.0±45.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.299±0.06 g/cm3(Predicted)
Storage 2-8°C

description Product Description

Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules in medicinal chemistry, especially in the design of drugs targeting viral infections and neurological disorders. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparation of kinase inhibitors and other enzyme modulators in research settings.

Available Sizes & Pricing

Size Availability Unit Price Quantity
250mg
10-20 days ฿8,000.00
1g
10-20 days ฿24,000.00
5g
10-20 days ฿79,680.00
1-((BENZYLOXY)CARBONYL)-3-AMINOPIPERIDINE-3-CARBOXYLIC ACID
No image available
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules in medicinal chemistry, especially in the design of drugs targeting viral infections and neurological disorders. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparation of kinase inhibitors and
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active compounds. Its structure supports the construction of complex molecules in medicinal chemistry, especially in the design of drugs targeting viral infections and neurological disorders. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparation of kinase inhibitors and other enzyme modulators in research settings.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...